Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 84

1.

The reasonable timing of the adjuvant radiotherapy in the treatment of uterine carcinosarcoma according to the surgical intent: suggestion based on progression patterns.

Yu JI, Choi DH, Huh SJ, Park W, Oh D, Bae DS.

Radiat Oncol J. 2013 Jun;31(2):72-80. doi: 10.3857/roj.2013.31.2.72. Epub 2013 Jun 30.

2.

The influence of adjuvant radiotherapy on patterns of failure and survivals in uterine carcinosarcoma.

Park HJ, Kim HJ, Wu HG, Kim H, Ha SW, Kang SB, Song YS, Park NH, Kim JW.

Radiat Oncol J. 2011 Dec;29(4):228-35. doi: 10.3857/roj.2011.29.4.228. Epub 2011 Dec 28.

3.

Uterine adenosarcoma with sarcomatous overgrowth versus uterine carcinosarcoma: comparison of treatment and survival.

Krivak TC, Seidman JD, McBroom JW, MacKoul PJ, Aye LM, Rose GS.

Gynecol Oncol. 2001 Oct;83(1):89-94.

PMID:
11585418
4.

Adjuvant radiotherapy and/or chemotherapy after surgery for uterine carcinosarcoma.

Galaal K, van der Heijden E, Godfrey K, Naik R, Kucukmetin A, Bryant A, Das N, Lopes AD.

Cochrane Database Syst Rev. 2013 Feb 28;(2):CD006812. doi: 10.1002/14651858.CD006812.pub3. Review.

PMID:
23450572
5.

Extracapsular axillary node extension in patients receiving adjuvant systemic therapy: an indication for radiotherapy?

Fisher BJ, Perera FE, Cooke AL, Opeitum A, Dar AR, Venkatesan VM, Stitt L, Radwan JS.

Int J Radiat Oncol Biol Phys. 1997 Jun 1;38(3):551-9.

PMID:
9231679
6.

Adjuvant radiotherapy and/or chemotherapy after surgery for uterine carcinosarcoma.

Galaal K, Godfrey K, Naik R, Kucukmetin A, Bryant A.

Cochrane Database Syst Rev. 2011 Jan 19;(1):CD006812. doi: 10.1002/14651858.CD006812.pub2. Review. Update in: Cochrane Database Syst Rev. 2013;2:CD006812.

7.

The Impact of Adjuvant Therapy on Survival and Recurrence Patterns in Women With Early-Stage Uterine Carcinosarcoma: A Multi-institutional Study.

Guttmann DM, Li H, Sevak P, Grover S, Jacobson G, Feldman A, Rubin S, Chu C, Bhatia S, Elshaikh MA, Lin LL.

Int J Gynecol Cancer. 2016 Jan;26(1):141-8. doi: 10.1097/IGC.0000000000000561.

PMID:
26509850
8.

Prognostic impact of epidermal growth factor receptor (EGFR) expression on loco-regional recurrence after preoperative radiotherapy in rectal cancer.

Azria D, Bibeau F, Barbier N, Zouhair A, Lemanski C, Rouanet P, Ychou M, Senesse P, Ozsahin M, Pèlegrin A, Dubois JB, Thèzenas S.

BMC Cancer. 2005 Jun 20;5:62.

9.

Adjuvant radiation therapy in gall bladder cancers: 10 years experience at Tata Memorial Hospital.

Mahantshetty UM, Palled SR, Engineer R, Homkar G, Shrivastava SK, Shukla PJ.

J Cancer Res Ther. 2006 Apr-Jun;2(2):52-6.

10.

Combination of adjuvant chemotherapy and radiotherapy is associated with improved survival at early stage type II endometrial cancer and carcinosarcoma.

Sozen H, Çiftçi R, Vatansever D, Topuz S, Iyibozkurt AC, Bozbey HU, Yaşa C, Çali H, Yavuz E, Kucucuk S, Aydiner A, Salihoglu Y.

Aust N Z J Obstet Gynaecol. 2016 Apr;56(2):199-206. doi: 10.1111/ajo.12449. Epub 2016 Feb 18.

PMID:
26890292
11.

Impact on Loco-regional Control of Radiochemotherapeutic Sequence and Time to Initiation of Adjuvant Treatment in Stage II/III Rectal Cancer Patients Treated with Postoperative Concurrent Radiochemotherapy.

Kim H, Chie EK, Ahn YC, Kim K, Park W, Yoon WS, Huh SJ, Ha SW.

Cancer Res Treat. 2014 Apr;46(2):148-57. doi: 10.4143/crt.2014.46.2.148. Epub 2014 Apr 22.

12.

Outcome analysis in patients with uterine sarcoma.

Yu T, Kim HJ, Wu HG, Ha SW, Song YS, Park NH, Kim JW.

Radiat Oncol J. 2015 Mar;33(1):29-35. doi: 10.3857/roj.2015.33.1.29. Epub 2015 Mar 31.

13.

Patterns of initial failure after resection for gallbladder cancer: implications for adjuvant radiotherapy.

Kim TG.

Radiat Oncol J. 2017 Dec;35(4):359-367. doi: 10.3857/roj.2017.00388. Epub 2017 Dec 20.

14.

Adjuvant chemo-radiotherapy in ampullary cancers.

Sikora SS, Balachandran P, Dimri K, Rastogi N, Kumar A, Saxena R, Kapoor VK.

Eur J Surg Oncol. 2005 Mar;31(2):158-63.

PMID:
15698732
15.

The role of cytoreductive surgery for newly diagnosed advanced-stage uterine carcinosarcoma.

Tanner EJ, Leitao MM Jr, Garg K, Chi DS, Sonoda Y, Gardner GJ, Barakat RR, Jewell EL.

Gynecol Oncol. 2011 Dec;123(3):548-52. doi: 10.1016/j.ygyno.2011.08.020. Epub 2011 Sep 25.

PMID:
21945551
16.

Clinical outcomes of uterine carcinosarcoma: results of 94 patients.

Gokce ZK, Turan T, Karalok A, Tasci T, Ureyen I, Ozkaya E, Kose MF, Tulunay G.

Int J Gynecol Cancer. 2015 Feb;25(2):279-87. doi: 10.1097/IGC.0000000000000347.

PMID:
25611900
17.

Adjuvant radio-chemotherapy for extrahepatic biliary tract cancers.

Bonet Beltrán M, Roth AD, Mentha G, Allal AS.

BMC Cancer. 2011 Jun 24;11:267. doi: 10.1186/1471-2407-11-267.

18.

Concurrent chemoradiotherapy in adjuvant treatment of breast cancer.

Ismaili N, Mellas N, Masbah O, Elmajjaoui S, Arifi S, Bekkouch I, Ahid S, Bazid Z, Tazi MA, Erraki A, El Mesbahi O, Benjaafar N, El Gueddari Bel K, Ismaili M, Afqir S, Errihani H.

Radiat Oncol. 2009 Apr 7;4:12. doi: 10.1186/1748-717X-4-12.

19.
20.

Patterns of failure for conservatively managed surgical stage I uterine carcinosarcoma: implications for adjuvant therapy.

Leath CA 3rd, Numnum TM, Kendrick JE 4th, Frederick PJ, Rocconi RP, Conner MG, Straughn JM Jr.

Int J Gynecol Cancer. 2009 Jul;19(5):888-91. doi: 10.1111/IGC.0b013e3181a831fb.

PMID:
19574779

Supplemental Content

Support Center